Respiratory Infections News

Gastrointestinal manifestations were prevalent among rural patients in Pennsylvania with COVID-19, with around a quarter reporting diarrhea — higher than in past studies — according to data reported in Open Forum Infectious Diseases.

A team of investigators who traveled to China did not find conclusive evidence of the origin of SARS-CoV-2, although they said humans were “likely to very likely” exposed through an intermediary animal host.

A study of more than 24,000 health care personnel found that community contact with COVID-19 increased the risk for being seropositive for SARS-CoV-2, but workplace exposure did not, according to results published in JAMA Network Open.

As COVID-19 cases begin to rise again, CDC Director Rochelle P. Walensky, MD, MPH, pleaded with Americans to “just please hold on a little while longer” and “get vaccinated when you can.”

The CDC has extended the eviction moratorium a second time to help prevent the spread of COVID-19.

Real-world data reported Monday in MMWR showed that the two COVID-19 messenger RNA vaccines authorized for use in the United States reduce the risk for SARS-CoV-2 infection by 90% 2 or more weeks after administration of the second dose.

Participants who received two doses of a messenger RNA COVID-19 vaccine were 80% less likely to test positive for asymptomatic SARS-CoV-2, according to real-world study results published in Clinical Infectious Diseases.

Pregnant and lactating women who received the Pfizer/BioNTech or Moderna COVID-19 vaccine had similar levels of vaccine-induced antibody titers compared with nonpregnant controls, according to new study results.

Dolutegravir-based ART with two nucleoside reverse transcriptase inhibitors was superior to standard of care among children with HIV enrolled in the international ODYSSEY trial, researchers reported at CROI.

The U.S. government, in collaboration with Eli Lilly, said it has halted the distribution of the drug maker’s monoclonal antibody bamlanivimab alone to treat COVID-19 because of concerns about emerging SARS-CoV-2 variants.